Screener
Rigel Pharmaceuticals RIGL Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
| Line item | As of / March 31, 2026 | As of / December 31, 2025 ⁽¹⁾ |
|---|---|---|
| Accounts receivable, net | 49,945 | 51,763 |
| Inventories | 11,652 | 11,506 |
| Prepaid and other current assets | 25,746 | 21,942 |
| Total current assets | 234,027 | 240,166 |
| Intangible assets, net | 24,160 | 24,748 |
| Deferred income tax asset | 243,279 | 245,852 |
| Operating lease right-of-use assets | 785 | 920 |
| Other assets | 2,357 | 1,908 |
Item 1. Financial Statements
FAQ
- What is Rigel Pharmaceuticals's total current assets?
- Rigel Pharmaceuticals (RIGL) reported total current assets of $234.03M in Q1 2026.
- How has Rigel Pharmaceuticals's total current assets changed year-over-year?
- Rigel Pharmaceuticals's total current assets increased by 59.7% year-over-year, from $146.56M to $234.03M.
- What is the long-term trend for Rigel Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's total current assets has grown at a 22.0% compound annual growth rate (CAGR), from $88.98M to $240.17M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Rigel Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude